Christopher Springate

Form D signer

Christopher Springate

Chief Executive Officer at ARC Medical

Form D signer

Capital raised by ARC Medical

$1.5M+$1.5M latest round

6 Form D filings · first filed Oct 2024

CURRENT ROLE: Chief Executive Officer
SECTOR: Healthcare
COMPANY FILINGS: 6
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: 2 ↗

Career

1 company on file

ARC MedicalHealthcaresince Oct 2024

Chief Executive Officer

Signatory on ARC Medical's Form D filings · $1.5M raised across 6

Company filings

via EDGAR · Form D for ARC Medical6

DateCompanyFormAmountRole on filing

Oct 4, 2024ARC MedicalForm D/A+$1.5MChief Executive Officer

Form D/AOct 4, 2024 · ARC Medical+$1.5Mas Chief Executive Officer

Oct 4, 2024ARC MedicalForm D/A+$1.4MChief Executive Officer

Form D/AOct 4, 2024 · ARC Medical+$1.4Mas Chief Executive Officer

Oct 4, 2024ARC MedicalForm D/A+$1.0MChief Executive Officer

Form D/AOct 4, 2024 · ARC Medical+$1.0Mas Chief Executive Officer

Oct 4, 2024ARC MedicalForm D/A+$901KChief Executive Officer

Form D/AOct 4, 2024 · ARC Medical+$901Kas Chief Executive Officer

Oct 4, 2024ARC MedicalForm D/A+$825KChief Executive Officer

Form D/AOct 4, 2024 · ARC Medical+$825Kas Chief Executive Officer

Oct 4, 2024ARC MedicalForm D/A+$589KChief Executive Officer

Form D/AOct 4, 2024 · ARC Medical+$589Kas Chief Executive Officer

Overview

Last filing Oct 4, 2024

Christopher Springate is on file as Chief Executive Officer at ARC Medical. ARC Medical has 6 Form D filings on record, $1.5M raised in total. Christopher Springate appears as a signatory on the company's filings.

Teammates

ARC Medical · 1

Deng MaoDirector

Products

ARC Medical · 1

IPCOAT™Surgical Adhesion Prevention

IPCOAT™ is an innovative liquid medical device utilized during gynecological and abdominal surgeries. It flows across the surgical site to form a protective barrier film over tissues, proactively preventing the occurrence of adhesions that can emerge post-surgery.